Yu Yan, Lu Dongying, Zhang Zhenhui, Tao Lili
Guangzhou Baiyunshan Hospital, Guangzhou, China.
Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Front Nutr. 2024 Feb 27;11:1275522. doi: 10.3389/fnut.2024.1275522. eCollection 2024.
Soluble transferrin receptor (sTfR)/log ferritin index (sTfR Index) can be used to assess the entire spectrum of iron status, and is valuable in evaluating iron status in population studies. There is still a lack of evidence on the association between sTfR index and all-cause mortality.
To explore the association between sTfR index and all-cause mortality, as well as mortality due to cardiovascular disease (CVD) and cancer.
Data were from the National Health and Nutrition Examination Survey (NHANES) between 2003 to 2020. Participants aged 16 years and older who had complete data of serum ferritin and sTfR were included. Pregnant individuals or those with ineligible data on death or follow-up were excluded from the analysis. Baseline sTfR index was calculated by baseline sTfR/log (ferritin) and classified as three tertile. We performed the Cox proportional hazard regression to assess the association of sTfR index (both continuous and categorical scale) with all-cause and cause-specific mortality and further assess the non-linear relationship between sTfR index and the outcomes with restricted cubic spline.
In this study, 11,525 participants, a total of 231 (2.0%) all-cause deaths occurred during a median follow-up of 51 months. The risk of all-cause mortality, CVD-related mortality, and cancer-related mortality was higher in participants with highest tertile of sTfR index. After confounding factors adjustment, participants with highest tertile of sTfR index were associated with an increased risk of all-cause mortality (HR: 1.71, 95% CI: 1.14-2.57) as compared with lowest tertile. Additionally, sTfR index per SD increment was associated with a 25% increasing risk of all-cause mortality (HR: 1.25, 95% CI: 1.08-1.45, = 0.003) and a 38% cancer-related mortality (HR: 1.38, 95% CI: 1.07-1.77, = 0.018). These associations remained robust after adjusting for the serum ferritin as well as in various subgroups stratified by age, sex, smoking statue, hypertension, diabetes, and CVD. Spline analysis showed that there is approximately linear relationship between sTfR index with all-cause mortality ( for non-linear = 0.481). Moreover, ferritin was not a predictor of all-cause death after adjustment for confounding factors.
This cohort study demonstrated a significant association between sTfR index increment and an increased risk of all-cause and cancer-related mortality, independent of ferritin levels.
可溶性转铁蛋白受体(sTfR)/铁蛋白对数指数(sTfR指数)可用于评估铁状态的全谱,在人群研究中评估铁状态具有重要价值。关于sTfR指数与全因死亡率之间的关联仍缺乏证据。
探讨sTfR指数与全因死亡率以及心血管疾病(CVD)和癌症所致死亡率之间的关联。
数据来自2003年至2020年的美国国家健康与营养检查调查(NHANES)。纳入年龄在16岁及以上且有血清铁蛋白和sTfR完整数据的参与者。分析排除孕妇或死亡或随访数据不合格者。基线sTfR指数通过基线sTfR/对数(铁蛋白)计算,并分为三个三分位数。我们进行Cox比例风险回归以评估sTfR指数(连续和分类尺度)与全因和特定原因死亡率的关联,并进一步用受限立方样条评估sTfR指数与结局之间的非线性关系。
在本研究中,11525名参与者,在中位随访51个月期间共发生231例(2.0%)全因死亡。sTfR指数最高三分位数的参与者全因死亡率、CVD相关死亡率和癌症相关死亡率的风险更高。在调整混杂因素后,sTfR指数最高三分位数的参与者与最低三分位数相比,全因死亡率风险增加(HR:1.71,95%CI:1.14 - 2.57)。此外,sTfR指数每增加一个标准差与全因死亡率风险增加25%(HR:1.25,95%CI:1.08 - 1.45,P = 0.003)和癌症相关死亡率增加38%(HR:1.38,95%CI:1.07 - 1.77,P = 0.018)相关。在调整血清铁蛋白以及按年龄、性别、吸烟状况、高血压、糖尿病和CVD分层的各个亚组中,这些关联仍然稳健。样条分析表明sTfR指数与全因死亡率之间存在近似线性关系(非线性检验P = 0.481)。此外,在调整混杂因素后,铁蛋白不是全因死亡的预测因素。
这项队列研究表明sTfR指数升高与全因和癌症相关死亡率风险增加之间存在显著关联,独立于铁蛋白水平。